Tracking quality of life and relapses in bladder cancer patients after surgery
Observational Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent Endoscopic Resection Surgery for Bladder Cancer (TURBK).
This study is tracking how bladder cancer patients feel and whether their cancer comes back after surgery over the next 10 years.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 20000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | IRCCS San Raffaele Academic / other |
| Locations | 1 site (Milan, MI) |
| Trial ID | NCT06167356 on ClinicalTrials.gov |
What this trial studies
This observational study collects data from adult patients who have undergone endoscopic resection surgeries for non-muscle invasive bladder cancer. Patients will be followed for approximately 10 years, with yearly follow-ups conducted via phone, email, or mail to gather information on their health status and quality of life. Data will be meticulously recorded in a secure database, adhering to strict guidelines for privacy and good clinical practices. The study aims to understand the occurrence of relapses and the overall quality of life in these patients over time.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older diagnosed with non-muscle invasive bladder cancer who are scheduled for endoscopic resection surgery.
Not a fit: Patients under 18 years old or those unable to read and sign the informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the long-term outcomes and quality of life for patients with non-muscle invasive bladder cancer.
How similar studies have performed: While similar studies have been conducted, this specific approach focusing on long-term quality of life and relapse tracking in this patient population is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years or older * Patients with non-muscle invasive bladder cancer * Indication to cancer removal through endoscopic resection surgery * Ability to read and sign the informed consent Exclusion Criteria: * Age \<18 years * Inability to read and sign the informed consent
Where this trial is running
Milan, MI
- IRCCS Ospedale San Raffaele — Milan, Mi, Italy (Recruiting)
Study contacts
- Principal investigator: Francesco Montorsi, MD — IRCCS Ospedale San Raffaele
- Study coordinator: Francesco Montorsi, MD
- Email: montorsi.francesco@hsr.it
- Phone: +390226437286
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.